system (CNS) and non-CNS marketed drugs. J Pharmacol Exp
Ther 303: 1029–1037.
Dufour A, Desanti C (1988). Pharmacocine ́tique et me ́tabolisme de
l'amisulpride. Ann Psychiatry 3: 298–305.
Eisenbla ̈tter T, Galla H-J (2002). A new multidrug resistance
protein at the blood–brain barrier. Biochem Biophys Res
Commun 293: 1273–1278.
Eisenbla ̈tter T, Hu ̈wel S, Galla H-J (2003). Characterisation of the
brain multidrug resistance protein (BMDP/ABCG2/BCRP) ex- pressed at the blood–brain barrier. Brain Res 971: 221–231.
Franke H, Galla H-J, Beuckmann CT (1999). An improved lowpermeability in vitro-model of the blood–brain barrier: transport
studies on retinoids, sucrose, haloperidol, caffeine and mannitol.
Brain Res 818: 65–71.
Franke H, Galla H-J, Beuckmann CT (2000). Primary cultures of
brain microvessel endothelial cells: a valid and flexible model to
study drug transport through the blood–brain barrier in vitro.
Brain Res Protoc 5: 248–256.
Gao B, Meier PJ (2001). Organic anion transport across the choroid
plexus. Microsc Res Techniq 52: 60–64.
Gath U, Hakvoort A, Wegener J, Decker S, Galla H-J (1997).
Porcine choroid plexus cells in culture: maintenance of barrier
properties and apical secretion of CSF components. Eur J Cell
Biol 74: 68–78.
Ghersi-Egea J-F, Strazielle N (2001). Brain drug delivery, drug
metabolism, and multidrug resistance at the choroid plexus.
Microsc Res Techniq 52: 83–88.
Grunder G, Wetzel H, Schlosser R, Anghelescu I, Hillert A, Lange K
et al (1999). Neuroendocrine response to antipsychotics: effects
of drug type and gender. Biol Psychiatry 45: 89–97.
Gutmann H, Toeroek M, Fricker G, Huwyler J, Beglinger C, Drewe
J (1999). Modulation of multidrug resistance protein expression
in porcine brain capillary endothelial cells in vitro. Drug Metab
Dispos 27: 937–941.
Hakvoort A, Haselbach M, Galla H-J (1998). Active transport
properties of porcine choroid plexus cells in culture. Brain Res
795: 247–256.
Haselbach M, Wegener J, Decker S, Engelbertz C, Galla H-J (2001).
Porcine choroid plexus epithelial cells in culture: regulation of
barrier properties and transport processes. Microsc Res Techniq
52: 137–152.
Henthorn TK, Liu Y, Mahapatro M, Ng K (1999). Active transport
of fentanyl by the blood–brain barrier. J Pharmacol Exp Ther
289: 1084–1089.
Hoheisel D, Nitz T, Franke H, Wegener J, Hakwoort A, Tilling T
et al (1998). Hydrocortisone reinforces the blood–brain barrier
properties in a serum free cell culture system. Biochem Biophys
Res Commun 244: 312–316.
King M, Su W, Chang A, Zuckerman A, Pasternak GW (2001).
Transport of opioids from the brain to the periphery by P- glycoprotein: peripheral actions of central drugs. Nat Neurosci 4:
268–274.
Leo AJ (1987). Some advantages of calculating octanol-water
partition coefficients. J Pharm Sci 76: 166–168.
Martinot JL, Paile ́re-Martinot M-L, Poirier ME, Dao-Castellana
MH, Loc'h C, Mazie ́re B (1996). In vivo characteristics of
dopamine D2 receptor occupancy by amisulpride in schizophrenia. Psychopharmacology 124: 154–158.
